This frequently asked question (FAQ) addresses the treatment of historical rate rollovers. It outlines regulatory expectations and reporting considerations.
These frequently asked questions (FAQs) address common questions on APRA’s industry supervision approach. They cover supervisory practices, expectations and regulatory interactions with regulated entities.
These frequently asked questions (FAQs) address common questions on margining and risk‑mitigation requirements for non‑centrally cleared derivatives, outlining regulatory expectations and reporting considerations for regulated entities.
These frequently asked questions (FAQs) support regulated entities in interpreting APS 111 on the capital treatment of derivative valuation adjustments (XVAs) and APS 116 on market risk arising from changes in funding valuation adjustments (FVA).
These frequently asked questions (FAQs) cover common questions on large exposure rules under APS 221 and ARS 221.0, including how exposures are assessed, limits applied, counterparties grouped and information reported by authorised deposit‑taking institutions.
These frequently asked questions (FAQs) cover common questions on APRA’s licensing process, outlining application stages, assessment considerations and post‑licensing obligations.
These frequently asked questions (FAQs) address common questions on activation payments and administrative arrangements under the Financial Claims Scheme. They outline how payments are managed when the scheme is activated.
These frequently asked questions (FAQs) address common questions about coverage under the Financial Claims Scheme. They outline how coverage applies when the scheme is activated.
These frequently asked questions (FAQs) explain how the Financial Claims Scheme protects banking deposits, including coverage limits, eligible accounts, and how protection applies across banks, joint accounts and trusts.